Metagenomi

About Metagenomi

Metagenomi is a company focused on creating potentially curative therapeutics using a metagenomics-powered genome editing toolbox. By harnessing the power of metagenomics, which involves studying genomes from uncultivated organisms in natural environments, they aim to develop novel genome editing tools to unlock the full therapeutic potential of gene editing and cure diseases.

Products & Services

Gene Editing Toolbox:A comprehensive and modular set of next-generation genome editing systems including programmable nucleases, base editors, and RNA- and DNA-mediated integration systems for precise corrections in the human genome.

Discovery Platform:Leverages artificial intelligence and metagenomics expertise to recover novel cellular systems from natural ecosystems, developing curative genetic medicines through high-throughput screening and AI-driven algorithms.

Therapeutic Focus:A stepwise approach to deploy genome editing tools for developing curative therapies, targeting devastating diseases and establishing new standards in precision and efficiency.

Specialties

Metagenomics Genome Editing Artificial Intelligence in Drug Discovery Genetic Medicines

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: IPO T: - FT: IPO	A: 93750000 MR: - FA: approximately $93.75 million FAN: 93750000	D: 2024-02-13 FD: 2024-02-13	6 investors
2	RT: IPO T: - FT: IPO	A: 93750000 MR: - FA: $93,750,000 FAN: 93750000	D: 2024-02-08 FD: 2024-02-08	6 investors
3	RT: Series B T: - FT: Series B	A: 275000000 MR: - FA: $275 million FAN: 275000000	D: 2023-01-05 FD: 2023-01-05	8 investors

IPO Latest

2024-02-13

$93.8M

6 investors (Pro only)

IPO 2024-02-08

$93.8M

Series B 2023-01-05

$275.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

B

Brian C. Thomas

CEO and Founder

LinkedIn (Pro only)

J

Jian Irish

President and Chief Operating Officer

LinkedIn (Pro only)

P

Pamela Wapnick

CFO

A

Alan Brooks

Head of Preclinical

C

Chris Brown

Head of Discovery

E

Eric Bjerkholt

CFO of Mirum Pharmaceuticals, Inc.

View 6 more team members with Pro

Unlock Full Team Directory

Recent News

Metagenomi Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised